GPT and metabolic dysfunction-associated steatotic liver disease: In agreement with our results, a recent study revealed a reduction in AST and ALT activity levels after using IAA to combat high-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) in C57BL/6 mice [27].